Почетна › Мажорна депресивна поремећеност › Вашингтон
Kliničke studije za Мажорна депресивна поремећеност u državi Вашингтон
19 studija za Мажорна депресивна поремећеност traži učesnike na lokacijama u državi Вашингтон.
Gradovi u državi Вашингтон
Zvanični tekst studije (na engleskom)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Core Clinical Research, Everett
- Seattle Neuropsychiatric Treatment Center, Seattle
Тражи се учесникФаза 3
Узраст од 18 до 85 · Оба пола · Ажурирано 13. 11. 2026. · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Everett
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 10. 11. 2026. · NCT07065240A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Seattle Neuropsychiatric Treatment Center, Seattle
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 9. 11. 2026. · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT07412756Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Core Clinical Research, Everett
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT06559306A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 11. 2026. · NCT07775300Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 3. 11. 2026. · NCT05850689A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Northwest Clinical Research Center, Bellevue
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT07573176Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Core Clinical Research, Everett
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 28. 10. 2026. · NCT07226661Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT07226232A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellevue
- Draig Clinical Site, Seattle
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 14. 10. 2026. · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bellevue
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07300969Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Bellevue
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 24. 9. 2026. · NCT06830044Positive Processes and Transition to Health (PATH)
- University of Washington, Seattle
Тражи се учесник
Узраст од 18 до 65 · Оба пола · Ажурирано 19. 8. 2026. · NCT06093906A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Northwest Clinical Research Center /ID# 277484, Bellevue
- Core Clinical Research /ID# 277518, Everett
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 15. 6. 2026. · NCT07276997Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #143, Bellevue
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 20. 1. 2026. · NCT06633016Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Everett
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2025. · NCT06786624A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Everett
Тражи се учесникФаза 4
Узраст од 18 до 65 · Оба пола · Ажурирано 23. 1. 2025. · NCT06223880InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI
- University of Washington Medical Center, Seattle
Тражи се учесник
Узраст од 18 до 64 · Оба пола · Ажурирано 19. 9. 2024. · NCT06005194Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.